Reverse mergers are all the rage as cash-depleted public biotechs search for viable next chapters, with Korro Bio and Frequency Therapeutics the latest to fuse. After two bouts of layoffs this year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results